Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack J Satsangi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Lancet. Gastroenterology & Hepatology|October 16, 2021
SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapyRania Selim, Judith Wellens, Luke Marlow, et al.
Gastroenterology|November 15, 2020
ReplyRebecca D Powell Doherty, Hanqing Liao, Jack J Satsangi, et al.
Gastroenterology|April 11, 2020
Extended Analysis Identifies Drug-Specific Association of 2 Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and InfliximabRebecca D Powell Doherty, Hanqing Liao, Jack J Satsangi, et al.
Journal of Crohn'S & Colitis|March 15, 2021
SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future ChallengesJudith Wellens, Jean-Frédéric Colombel, Jack J Satsangi, et al.
The Lancet. Gastroenterology & Hepatology|September 24, 2022
Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapyRania Selim, Judith Wellens, Stephanie Brann, et al.
The Lancet. Gastroenterology & Hepatology|April 9, 2022
Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel diseaseJudith Wellens, Stephanie Brann, Alex Adams, et al.
The Lancet. Gastroenterology & Hepatology|October 11, 2025
Peripheral blood DNA methylation signatures to predict treatment response in Crohn's disease - Authors' replyAndrew Y F Li Yim, Evgeni Levin, Wouter J de Jonge, et al.
The Lancet. Gastroenterology & Hepatology|July 4, 2025
Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD): an epigenome-wide association studyVincent W Joustra, Andrew Y F Li Yim, Peter Henneman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Lancet. Gastroenterology & Hepatology|October 16, 2021
SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapyRania Selim, Judith Wellens, Luke Marlow, et al.
Gastroenterology|November 15, 2020
ReplyRebecca D Powell Doherty, Hanqing Liao, Jack J Satsangi, et al.
Gastroenterology|April 11, 2020
Extended Analysis Identifies Drug-Specific Association of 2 Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and InfliximabRebecca D Powell Doherty, Hanqing Liao, Jack J Satsangi, et al.
Journal of Crohn'S & Colitis|March 15, 2021
SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future ChallengesJudith Wellens, Jean-Frédéric Colombel, Jack J Satsangi, et al.
The Lancet. Gastroenterology & Hepatology|September 24, 2022
Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapyRania Selim, Judith Wellens, Stephanie Brann, et al.
The Lancet. Gastroenterology & Hepatology|April 9, 2022
Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel diseaseJudith Wellens, Stephanie Brann, Alex Adams, et al.
The Lancet. Gastroenterology & Hepatology|October 11, 2025
Peripheral blood DNA methylation signatures to predict treatment response in Crohn's disease - Authors' replyAndrew Y F Li Yim, Evgeni Levin, Wouter J de Jonge, et al.
The Lancet. Gastroenterology & Hepatology|July 4, 2025
Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD): an epigenome-wide association studyVincent W Joustra, Andrew Y F Li Yim, Peter Henneman, et al.
Pageof 1